JP2018184448A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018184448A5 JP2018184448A5 JP2018139536A JP2018139536A JP2018184448A5 JP 2018184448 A5 JP2018184448 A5 JP 2018184448A5 JP 2018139536 A JP2018139536 A JP 2018139536A JP 2018139536 A JP2018139536 A JP 2018139536A JP 2018184448 A5 JP2018184448 A5 JP 2018184448A5
- Authority
- JP
- Japan
- Prior art keywords
- hematopoietic stem
- cells
- cell
- use according
- progenitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37321210P | 2010-08-12 | 2010-08-12 | |
| US61/373,212 | 2010-08-12 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018031941A Division JP6574279B2 (ja) | 2010-08-12 | 2018-02-26 | 改善された造血幹細胞および前駆細胞療法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019197587A Division JP2020029458A (ja) | 2010-08-12 | 2019-10-30 | 改善された造血幹細胞および前駆細胞療法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018184448A JP2018184448A (ja) | 2018-11-22 |
| JP2018184448A5 true JP2018184448A5 (https=) | 2019-01-10 |
Family
ID=45568224
Family Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013524254A Expired - Fee Related JP6047489B2 (ja) | 2010-08-12 | 2011-08-12 | 改善された造血幹細胞および前駆細胞療法 |
| JP2016124416A Expired - Fee Related JP6346917B2 (ja) | 2010-08-12 | 2016-06-23 | 改善された造血幹細胞および前駆細胞療法 |
| JP2018031941A Expired - Fee Related JP6574279B2 (ja) | 2010-08-12 | 2018-02-26 | 改善された造血幹細胞および前駆細胞療法 |
| JP2018139536A Withdrawn JP2018184448A (ja) | 2010-08-12 | 2018-07-25 | 改善された造血幹細胞および前駆細胞療法 |
| JP2019197587A Withdrawn JP2020029458A (ja) | 2010-08-12 | 2019-10-30 | 改善された造血幹細胞および前駆細胞療法 |
| JP2021172986A Withdrawn JP2022009404A (ja) | 2010-08-12 | 2021-10-22 | 改善された造血幹細胞および前駆細胞療法 |
| JP2023071598A Pending JP2023109761A (ja) | 2010-08-12 | 2023-04-25 | 改善された造血幹細胞および前駆細胞療法 |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013524254A Expired - Fee Related JP6047489B2 (ja) | 2010-08-12 | 2011-08-12 | 改善された造血幹細胞および前駆細胞療法 |
| JP2016124416A Expired - Fee Related JP6346917B2 (ja) | 2010-08-12 | 2016-06-23 | 改善された造血幹細胞および前駆細胞療法 |
| JP2018031941A Expired - Fee Related JP6574279B2 (ja) | 2010-08-12 | 2018-02-26 | 改善された造血幹細胞および前駆細胞療法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019197587A Withdrawn JP2020029458A (ja) | 2010-08-12 | 2019-10-30 | 改善された造血幹細胞および前駆細胞療法 |
| JP2021172986A Withdrawn JP2022009404A (ja) | 2010-08-12 | 2021-10-22 | 改善された造血幹細胞および前駆細胞療法 |
| JP2023071598A Pending JP2023109761A (ja) | 2010-08-12 | 2023-04-25 | 改善された造血幹細胞および前駆細胞療法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20140030232A1 (https=) |
| EP (2) | EP2603227B1 (https=) |
| JP (7) | JP6047489B2 (https=) |
| CN (5) | CN112501118A (https=) |
| AU (1) | AU2011289245B2 (https=) |
| BR (1) | BR112013003366A2 (https=) |
| CA (1) | CA2807944C (https=) |
| ES (1) | ES2654994T3 (https=) |
| WO (1) | WO2012021845A2 (https=) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2603227B1 (en) * | 2010-08-12 | 2017-10-04 | Fate Therapeutics, Inc. | Improved hematopoietic stem and progenitor cell therapy |
| US10111907B2 (en) | 2011-12-02 | 2018-10-30 | Fate Therapeutics, Inc. | Methods of treating ischemia |
| EP3785767A1 (en) * | 2011-12-02 | 2021-03-03 | Fate Therapeutics, Inc. | Enhanced stem cell composition |
| WO2014078617A1 (en) * | 2012-11-16 | 2014-05-22 | Albert Einstein College Of Medicine Of Yeshiva University | Identification and use of new tumor-promoting gene in hematological malignancies |
| CN113913366B (zh) * | 2013-02-18 | 2025-01-10 | 大学健康网络 | 由多能干细胞生成肝细胞和胆管细胞的方法 |
| EP2970881A4 (en) * | 2013-03-14 | 2017-01-25 | Children's Medical Center Corporation | Compositions and methods for reprogramming hematopoietic stem cell lineages |
| US10851412B2 (en) | 2013-03-15 | 2020-12-01 | Fate Therapeutics, Inc. | Cell potency assay for therapeutic potential |
| US9943545B2 (en) | 2013-03-15 | 2018-04-17 | Fate Therapeutics, Inc. | Stem cell culture media and methods of enhancing cell survival |
| WO2014140921A2 (en) | 2013-03-15 | 2014-09-18 | Larsson Marcus Kare Torleif | Cells, methods and apparatuses for umbilical cord blood collection and isolation of cells |
| RU2525143C1 (ru) * | 2013-03-22 | 2014-08-10 | Федеральное государственное бюджетное учреждение науки Государственный научный центр Российской Федерации-Институт медико-биологических проблем Российской академии наук | СПОСОБ ЭКСПАНСИИ МОНОНУКЛЕАРНЫХ КЛЕТОК ПУПОВИННОЙ КРОВИ (пкМНК) ex vivo В ПРИСУТСТВИИ МУЛЬТИПОТЕНТНЫХ СТРОМАЛЬНЫХ МЕЗЕНХИМАЛЬНЫХ КЛЕТОК (ММСК) |
| WO2015077691A2 (en) * | 2013-11-22 | 2015-05-28 | Washington University | Biomarkers for multiple myeloma |
| US11278572B2 (en) | 2014-07-18 | 2022-03-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Reducing CXCR4 expression and/or function to enhance engraftment of hematopoietic stem cells |
| AU2016211671B2 (en) | 2015-01-26 | 2022-05-26 | Fate Therapeutics, Inc. | Methods and compositions for inducing hematopoietic cell differentiation |
| US20180112180A1 (en) * | 2015-01-26 | 2018-04-26 | Fate Therapeutics, Inc. | Cells with increased immuno-regulatory properties and methods for their use and manufacture |
| HK1249534A1 (zh) * | 2015-04-06 | 2018-11-02 | 哈佛大学校长及研究员协会 | 用於非清髓性预处理的组合物和方法 |
| EP4202036A1 (en) * | 2015-07-20 | 2023-06-28 | Angiocrine Bioscience, Inc. | Methods and compositions for stem cell transplantation |
| RU2018106515A (ru) | 2015-07-21 | 2019-08-21 | Зе Чилдрен'С Медикал Сентер Корпорейшн | Pd-l1-экспрессирующие гемопоэтические стволовые клетки и применения |
| CA3003152A1 (en) | 2015-11-04 | 2017-05-11 | Fate Therapeutics, Inc. | Methods and compositions for inducing hematopoietic cell differentiation |
| JP6928604B2 (ja) | 2015-11-04 | 2021-09-01 | フェイト セラピューティクス，インコーポレイテッド | 万能性細胞のゲノム改変 |
| EP3411475B1 (en) * | 2016-02-06 | 2025-08-27 | President and Fellows of Harvard College | Recapitulating the hematopoietic niche to reconstitute immunity |
| RU2628092C1 (ru) * | 2016-02-10 | 2017-08-14 | Федеральное государственное бюджетное учреждение науки Государственный научный центр Российской Федерации - Институт медико-биологических проблем Российской академии наук (ГНЦ РФ - ИМБП РАН) | Способ получения МСК-ассоциированных недифференцированных гемопоэтических клеток-предшественников с фенотипов CD34+/CD133+ |
| CN105779386B (zh) * | 2016-04-06 | 2019-09-20 | 南京大学 | 一种间充质干细胞在制备治疗m5型白血病药物中的应用 |
| CN105886457A (zh) * | 2016-05-16 | 2016-08-24 | 中国人民解放军军事医学科学院野战输血研究所 | 诱导干细胞分化成外胚层祖细胞的方法 |
| US11542473B2 (en) | 2016-10-21 | 2023-01-03 | Amniotics Ab | Methods and compositions for generating hematopoietic cells |
| CN106754726A (zh) * | 2016-12-28 | 2017-05-31 | 溯源生命科技股份有限公司 | 一种提高人间充质干细胞移植和归巢效率的基因治疗方法 |
| US20200051666A1 (en) * | 2017-03-14 | 2020-02-13 | Orig3N, Inc. | HLA-INDEXED REPOSITORY OF iPSCS AND iPSC-DERIVED STEM CELLS, AND RELATED SYSTEMS AND METHODS |
| WO2019060708A1 (en) | 2017-09-22 | 2019-03-28 | The Children's Medical Center Corporation | TREATMENT OF TYPE 1 DIABETES AND AUTOIMMUNE DISEASES OR DISORDERS |
| EP3647413A1 (en) * | 2018-10-31 | 2020-05-06 | Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas O.A., M.P. (CIEMAT) | Improvements for performing and facilitating the recovery after hematopoietic stem cell transplantation |
| EP3969018A4 (en) * | 2019-05-17 | 2023-07-12 | Deverra Therapeutics Inc. | Compositions and methods for improving treatment outcomes for patients having hematological malignancies using an expanded stem cell product |
| WO2020247341A1 (en) * | 2019-06-06 | 2020-12-10 | Medeor Therapeutics, Inc. | Methods of making cellular products by post-mortem mobilization and harvesting of hematopoietic cells |
| WO2020256628A1 (en) | 2019-06-20 | 2020-12-24 | Amniotics Ab | An apparatus for filtering amniotic fluid |
| CN110585432B (zh) * | 2019-08-27 | 2021-10-15 | 中国人民解放军第二军医大学 | 成纤维细胞生长因子受体1在制备防治肠道病毒71型感染药物中的应用 |
| AU2020368845A1 (en) | 2019-10-18 | 2022-05-12 | Amniotics Ab | Processes and apparatuses for obtaining amniotic mesenchymal stem cells from amniotic fluid and cells derived thereof |
| WO2021097346A1 (en) * | 2019-11-14 | 2021-05-20 | Amgen Inc. | Hematopoietic precursor cell production |
| CN116507346A (zh) * | 2020-09-24 | 2023-07-28 | 广州辑因医疗科技有限公司 | 化合物用于提高人造血干细胞移植效率的用途 |
| WO2022089606A1 (en) * | 2020-10-30 | 2022-05-05 | Westlake Therapeutics (Hangzhou) Co. Limited | Methods for preparing mature red blood cells in vitro |
| US12435308B2 (en) | 2020-11-06 | 2025-10-07 | Amniotics Ab | Immunomodulation by amniotic fluid mesenchymal stem cells |
| WO2024040061A2 (en) * | 2022-08-16 | 2024-02-22 | The Regents Of The University Of California | Alleviating graft versus host disease using engineered inkt cells |
| WO2024186146A1 (ko) * | 2023-03-07 | 2024-09-12 | 인제대학교 산학협력단 | 조혈 줄기세포 증식 또는 가동화 촉진용 조성물 및 가동화 조혈 줄기세포 수집방법 |
| WO2026079443A1 (ja) * | 2024-10-09 | 2026-04-16 | 国立大学法人 東京大学 | Ｃｘｃｒ４陽性造血幹細胞の誘導または製造方法および前記ｃｘｃｒ４陽性造血幹細胞を含む細胞集団 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4843155A (en) | 1987-11-19 | 1989-06-27 | Piotr Chomczynski | Product and process for isolating RNA |
| US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| US5061620A (en) | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
| US5635387A (en) | 1990-04-23 | 1997-06-03 | Cellpro, Inc. | Methods and device for culturing human hematopoietic cells and their precursors |
| US5460964A (en) | 1992-04-03 | 1995-10-24 | Regents Of The University Of Minnesota | Method for culturing hematopoietic cells |
| US5409813A (en) | 1993-09-30 | 1995-04-25 | Systemix, Inc. | Method for mammalian cell separation from a mixture of cell populations |
| US5677136A (en) | 1994-11-14 | 1997-10-14 | Systemix, Inc. | Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof |
| US5709472A (en) * | 1995-10-23 | 1998-01-20 | Lifelines Technology, Inc. | Time-temperature indicator device and method of manufacture |
| US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
| EP0880598A4 (en) | 1996-01-23 | 2005-02-23 | Affymetrix Inc | RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM |
| US5945337A (en) | 1996-10-18 | 1999-08-31 | Quality Biological, Inc. | Method for culturing CD34+ cells in a serum-free medium |
| EP1027456B1 (en) | 1997-10-31 | 2005-03-16 | Affymetrix, Inc. (a Delaware Corporation) | Expression profiles in adult and fetal organs |
| US6020135A (en) | 1998-03-27 | 2000-02-01 | Affymetrix, Inc. | P53-regulated genes |
| AU2183900A (en) | 1998-12-24 | 2000-07-31 | Alcon Laboratories, Inc. | Ep4 receptor agonists for treatment of dry eye |
| AU770867B2 (en) | 1999-08-13 | 2004-03-04 | Fumie Sato | Prostaglandin derivatives |
| IL141120A0 (en) | 2000-01-31 | 2002-02-10 | Pfizer Prod Inc | Use of prostaglandin (pge2) receptor 4 (epa) selective agonists for the treatment of acute and chronic renal failure |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| FR2825261B1 (fr) | 2001-06-01 | 2003-09-12 | Maco Pharma Sa | Ligne de prelevement du sang placentaire comprenant une poche de rincage |
| US7439332B2 (en) * | 2002-04-26 | 2008-10-21 | Kirin Pharma Kabushiki Kaisha | Polypeptide having an activity to support proliferation or survival of hematopoietic stem or progenitor cells |
| US6747037B1 (en) | 2003-06-06 | 2004-06-08 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
| US20050176140A1 (en) * | 2004-02-10 | 2005-08-11 | Benedict Daniel J. | Method and apparatus for cell culture using a two liquid phase bioreactor |
| US7147626B2 (en) | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
| AU2005299473B2 (en) | 2004-10-26 | 2012-06-28 | Allergan, Inc. | Therapeutic and delivery methods of prostaglandin EP4 agonists |
| DE102005062741A1 (de) | 2005-12-22 | 2007-06-28 | Bayer Schering Pharma Ag | Fluorene und Carbazole als Liganden des EP2 Rezeptors |
| EP3424507A1 (en) * | 2006-03-24 | 2019-01-09 | Children's Medical Center Corporation | Method to modulate hematopoietic stem cell growth |
| CN101517070A (zh) * | 2006-05-31 | 2009-08-26 | Styx有限责任公司 | 选择干细胞的方法及其用途 |
| CN101506353A (zh) * | 2006-06-15 | 2009-08-12 | 尼奥斯泰姆公司 | 外周造血干细胞的处理方法 |
| WO2009134532A2 (en) * | 2008-03-07 | 2009-11-05 | The Trustees Of Columbia University In The City Of New York | Homing in mesenchymal stem cells |
| PT3031907T (pt) * | 2008-11-06 | 2021-01-28 | Univ Indiana Res & Tech Corp | Materiais e métodos para melhorar procedimentos de enxerto de células estaminais hematopoiéticas |
| CN102245189B (zh) * | 2008-12-03 | 2015-06-17 | 阿莫塞特公司 | 改善梗死区灌注的组合物以及血管损伤修复方法 |
| JP2010193879A (ja) * | 2009-01-27 | 2010-09-09 | Jms Co Ltd | 臍帯血造血幹細胞の増殖制御方法およびその用途 |
| EP2603227B1 (en) * | 2010-08-12 | 2017-10-04 | Fate Therapeutics, Inc. | Improved hematopoietic stem and progenitor cell therapy |
-
2011
- 2011-08-12 EP EP11817137.0A patent/EP2603227B1/en not_active Not-in-force
- 2011-08-12 EP EP17188681.5A patent/EP3278808A1/en not_active Withdrawn
- 2011-08-12 CA CA2807944A patent/CA2807944C/en active Active
- 2011-08-12 CN CN202011443538.1A patent/CN112501118A/zh active Pending
- 2011-08-12 CN CN201610638252.6A patent/CN106214701B/zh not_active Expired - Fee Related
- 2011-08-12 WO PCT/US2011/047657 patent/WO2012021845A2/en not_active Ceased
- 2011-08-12 ES ES11817137.0T patent/ES2654994T3/es active Active
- 2011-08-12 CN CN201610635871.XA patent/CN106244547B/zh not_active Expired - Fee Related
- 2011-08-12 BR BR112013003366-5A patent/BR112013003366A2/pt not_active Application Discontinuation
- 2011-08-12 AU AU2011289245A patent/AU2011289245B2/en not_active Ceased
- 2011-08-12 US US13/816,723 patent/US20140030232A1/en not_active Abandoned
- 2011-08-12 CN CN201180049420.3A patent/CN103167876B/zh not_active Expired - Fee Related
- 2011-08-12 CN CN202011436734.6A patent/CN112516167A/zh active Pending
- 2011-08-12 JP JP2013524254A patent/JP6047489B2/ja not_active Expired - Fee Related
-
2016
- 2016-06-23 JP JP2016124416A patent/JP6346917B2/ja not_active Expired - Fee Related
-
2018
- 2018-02-26 JP JP2018031941A patent/JP6574279B2/ja not_active Expired - Fee Related
- 2018-07-25 JP JP2018139536A patent/JP2018184448A/ja not_active Withdrawn
-
2019
- 2019-10-30 JP JP2019197587A patent/JP2020029458A/ja not_active Withdrawn
-
2020
- 2020-05-11 US US16/872,061 patent/US20200339953A1/en not_active Abandoned
-
2021
- 2021-10-22 JP JP2021172986A patent/JP2022009404A/ja not_active Withdrawn
-
2023
- 2023-04-25 JP JP2023071598A patent/JP2023109761A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018184448A5 (https=) | ||
| Haider et al. | Bone marrow stem cell transplantation for cardiac repair | |
| ES2627043T3 (es) | Aumento de la eficacia de la terapia celular incluyendo tratamiento con alfa 1-3 fucoslitransferasa | |
| Aggarwal et al. | Hematopoietic stem cells: transcriptional regulation, ex vivo expansion and clinical application | |
| Zhong et al. | Feasibility investigation of allogeneic endometrial regenerative cells | |
| Malgieri et al. | Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art | |
| Sieveking et al. | Cell therapies for therapeutic angiogenesis: back to the bench | |
| Tung et al. | Ex vivo expansion of umbilical cord blood for transplantation | |
| ES2638435T3 (es) | Métodos y medios para proliferación de células madre y posterior generación y expansión de células progenitoras, así como también producción de células efectoras como terapéuticos clínicos | |
| US20240294873A1 (en) | Methods for the long-term expansion of granulocyte-macrophage progenitors and applications thereof | |
| JP2013540105A5 (https=) | ||
| RU2015134394A (ru) | Перепрограммирование эндотелия человека в гемопоэтических предшественников множественных линий дифференцировки с использованием определенных факторов | |
| Lo Iacono et al. | Wharton’s jelly mesenchymal stromal cells as a feeder layer for the ex vivo expansion of hematopoietic stem and progenitor cells: a review | |
| JP2021512903A5 (https=) | ||
| JP2024016037A5 (https=) | ||
| Wang et al. | Allogeneic stem cell transplantation combined with transfusion of mesenchymal stem cells in primary myelofibrosis: a multicenter retrospective study | |
| US20190201444A1 (en) | Glycoengineering of e-selectin ligands | |
| US20110206644A1 (en) | Methods for trans-differentiating cells | |
| Kim et al. | Cell therapy with bone marrow cells for myocardial regeneration | |
| Metheny et al. | Posttransplant intramuscular injection of PLX-R18 mesenchymal-like adherent stromal cells improves human hematopoietic engraftment in a murine transplant model | |
| Quesenberry et al. | The new stem cell biology | |
| Turksen | Stem cells: Current challenges and new directions | |
| Aanei et al. | Evaluation of bone marrow microenvironment could change how myelodysplastic syndromes are diagnosed and treated | |
| Ren et al. | Umbilical cord blood hematopoietic stem cell expansion ex vivo | |
| Cetrulo et al. | Perinatal stem cells |